Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms
- PMID: 22988490
- PMCID: PMC3439985
- DOI: 10.1155/2012/505274
Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms
Abstract
Pulmonary hypertension (PH) is a potentially life-threatening condition arising from a wide variety of pathophysiologic mechanisms. Effective treatment requires a systematic diagnostic approach to identify all reversible mechanisms. Many of these mechanisms are relevant to those afflicted with obesity. The unique mechanisms of PH in the obese include obstructive sleep apnea, obesity hypoventilation syndrome, anorexigen use, cardiomyopathy of obesity, and pulmonary thromboembolic disease. Novel mechanisms of PH in the obese include endothelial dysfunction and hyperuricemia. A wide range of effective therapies exist to mitigate the disability of PH in the obese.
References
-
- Mukerjee D, George DS, Knight C, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology. 2004;43(4):461–466. - PubMed
-
- McLaughlin VV, Archer SL, Badesch DB, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the american college of cardiology foundation task force on expert consensus documents and the american heart association developed in collaboration with the american college of chest physicians; american thoracic society, inc.; and the pulmonary hypertension association. Journal of the American College of Cardiology. 2009;53(17):1573–1619. - PubMed
-
- Humbert M, Sitbon O, Chaouat A, et al. Pulmonary arterial hypertension in France: results from a national registry. American Journal of Respiratory and Critical Care Medicine. 2006;173(9):1023–1030. - PubMed
-
- Hatano S, Strasser R, editors. Primary pulmonary hypertension. World Heath Organization, Geneva, Switzerland, 1975.
LinkOut - more resources
Full Text Sources
Other Literature Sources
